| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $17.4B | — | — | — | — |
| Op. Income | $2.8B | — | — | — | — |
| Gross Margin | 44.6% | — | — | — | — |
| Net Margin | 6.3% | — | — | — | — |
| EPS (Diluted) | $1.60 | — | — | — | — |
| Free Cash Flow | $2.8B | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $17.4B |
| Cost of Revenue | $9.6B |
| GROSS PROFIT | $7.8B |
| R&D Expenses | $1.5B |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $3.5B |
| Other Expenses | $0 |
| Operating Expenses | $5.0B |
| Cost & Expenses | $14.6B |
| OPERATING INCOME | $2.8B |
| Interest Income | $136M |
| Interest Expense | $180M |
| Other Income/Expenses | -$1.1B |
| INCOME BEFORE TAX | $1.7B |
| Income Tax Expense | $484M |
| Net Income from Continuing Ops | $1.2B |
| Net Income from Discontinued Ops | -$99M |
| Other Adjustments | $0 |
| NET INCOME | $1.1B |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $1.1B |
| D&A | $1.2B |
| EBIT | $2.8B |
| EBITDA | $4.0B |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| REVENUE | $17.4B |
| Cost of Revenue | $9.6B |
| GROSS PROFIT | $7.8B |
| R&D Expenses | $1.5B |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $3.5B |
| Other Expenses | $0 |
| Operating Expenses | $5.0B |
| Cost & Expenses | $14.6B |
| OPERATING INCOME | $2.8B |
| Interest Income | $136M |
| Interest Expense | $180M |
| Other Income/Expenses | -$1.1B |
| INCOME BEFORE TAX | $1.7B |
| Income Tax Expense | $484M |
| Net Income from Continuing Ops | $1.2B |
| Net Income from Discontinued Ops | -$99M |
| Other Adjustments | $0 |
| NET INCOME | $1.1B |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $1.1B |
| D&A | $1.2B |
| EBIT | $2.8B |
| EBITDA | $4.0B |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| Net Income | $1.1B |
| Depreciation & Amortization | $1.2B |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | -$41M |
| Other Non-Cash Items | $598M |
| Change in Working Capital | $541M |
| OPERATING CASH FLOW | $3.4B |
| Capital Expenditure | -$591M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $11M |
| Other Investing Activities | $37M |
| NET CASH FROM INVESTING | -$543M |
| Net Debt Issuance | -$141M |
| Common Stock Repurchased | -$1.1B |
| Common Dividends Paid | -$475M |
| Other Financing Activities | -$1.1B |
| NET CASH FROM FINANCING | -$1.6B |
| FREE CASH FLOW | $2.8B |
| Net Change in Cash | $1.3B |
| Item | Amount |
|---|---|
| Cash & Equivalents | $4.5B |
| Short-Term Investments | $9M |
| Net Receivables | $6.4B |
| Inventory | $5.7B |
| Other Current Assets | $767M |
| TOTAL CURRENT ASSETS | $17.3B |
| PP&E (Net) | $9.6B |
| Goodwill | $10.5B |
| Intangible Assets | $8.3B |
| Long-Term Investments | $160M |
| Tax Assets | $320M |
| Other Non-Current Assets | -$3.3B |
| TOTAL NON-CURRENT ASSETS | $25.5B |
| TOTAL ASSETS | $42.8B |
| Account Payables | $4.4B |
| Short-Term Debt | $1.0B |
| Deferred Revenue | $3.6B |
| Other Current Liabilities | -$122M |
| TOTAL CURRENT LIABILITIES | $12.1B |
| Long-Term Debt | $1.7B |
| Deferred Revenue NC | $125M |
| Deferred Tax Liabilities | $251M |
| Other Non-Current Liabilities | $4.0B |
| TOTAL NON-CURRENT LIABILITIES | $6.3B |
| TOTAL LIABILITIES | $18.5B |
| Common Stock | $7M |
| Additional Paid-In Capital | $27.0B |
| Retained Earnings | -$67M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$2.8B |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $24.1B |
| Minority Interest | $242M |
| TOTAL EQUITY | $24.4B |
| TOTAL LIABILITIES & EQUITY | $42.8B |
| Total Debt | $2.6B |
| Net Debt | -$1.9B |
